株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

体外診断 (IVD) の世界市場 - 分析と予測:2028年までの業界予測

Global In-Vitro Diagnostics Market Analysis & Trends - Industry Forecast to 2028

発行 Accuray Research 商品コード 942178
出版日 ページ情報 英文 160 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
体外診断 (IVD) の世界市場 - 分析と予測:2028年までの業界予測 Global In-Vitro Diagnostics Market Analysis & Trends - Industry Forecast to 2028
出版日: 2020年06月01日 ページ情報: 英文 160 Pages
概要

世界の体外診断 (IVD) 市場は、2028年までの予測期間中、約5.5%のCAGRで成長する構えを見せています。 市場におけるいくつかの有望な動向は、新興市場におけるヘルスケア支出の増加、技術的に高度な検査方法に対する需要の急増、および慢性疼痛の発症率の上昇などです。

当レポートでは、世界の体外診断 (IVD) 市場について調査し、市場の概要とダイナミクス、各セグメント・地域別による市場の分析と予測、および主要企業のプロファイルなどを提供しています。

第1章 市場の概略

第2章 エグゼクティブサマリー

第3章 市場概要

  • 現在の動向
    • 新興市場でのヘルスケア費の増加
    • 技術的に高度な試験方法に対する大きな需要
    • 慢性疾患の発生率の上昇
    • 成長機会/投資機会
  • 促進要因
  • 抑制要因
  • 業界の魅力
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係

第4章 体外診断 (IVD) 市場:製品別

  • データ管理ソフトウェア
  • 試薬とキット
  • 装置
  • ソフトウェアとサービス
  • 消耗品

第5章 体外診断 (IVD) 市場:アプリケーション別

  • 心臓病
  • 感染症
  • 薬物検査/薬理ゲノミクス
  • 循環器
  • 糖尿病
  • 腎臓学
  • HIV /エイズ
  • 自己免疫疾患
  • その他の用途

第6章 体外診断 (IVD) 市場:技術別

  • 分子診断(MDX)
    • ポリメラーゼ連鎖反応(PCR)
    • ハイブリダイゼーション
    • 等温核酸増幅技術(INAAT)
    • マイクロアレイ
    • DNA診断
    • その他のMDX技術
  • 免疫化学/免疫アッセイ
    • 酵素免疫測定法(ELISA)
    • ウエスタンブロット法
    • 迅速試験
    • 放射免疫測定(RIA)
    • 酵素結合イムノスポット(ELISPOT)アッセイ
  • 臨床化学
    • 肝パネル
    • 腎臓プロファイル
    • 電解質パネル
    • 基礎的な生化学検査 (BMP)
    • 甲状腺機能パネル
    • 特殊化学試験
  • 臨床微生物学
  • 凝固と止血
  • 血液学
  • その他のIVD技術

第7章 体外診断 (IVD) 市場:エンドユーザー別

  • 独立研究機関
  • 病院
  • 学術機関
  • 患者の自己診断 (PST)
  • ポイントオブケア検査 (POCT)
  • その他のエンドユーザー

第8章 地域 世界の体外診断薬の市場

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • アジア太平洋のその他諸国
  • 中東
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東
  • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • その他ラテンアメリカ
  • その他
    • アフリカ
    • カリブ海諸国

第9章 主要企業の活動

  • 合併と買収
  • パートナーシップ、ジョイントベンチャー、コラボレーション、および契約
  • 製品の発売と拡張
  • 他の活動

第10章 主要企業

  • Johnson & Johnson
  • Sysmex Corporation
  • Biomerieux SA
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Alere Inc.
  • Thermo Fisher Scientific, Inc.
  • Bristol-Myers Squibb Company
  • Abbott Laboratories, Inc.
  • Ortho-Clinical Diagnostics, Inc.
  • Diasorin S.P.A.
  • Bio-Rad Laboratories, Inc.
  • Siemens AG
  • Arkray, Inc.
  • Qiagen N.V.
  • Roche Diagnostics
  • Affymetrix Inc.
図表

List of Tables

  • Table 1 Global In Vitro Diagnostics Market By Region, Market forecast (2017-2028) (US $MN)
  • Table 2 Global In Vitro Diagnostics Market By Product, Market forecast (2017-2028) (US $MN)
  • Table 3 Global In Vitro Diagnostics Market By Data Management Software, Market forecast (2017-2028) (US $MN)
  • Table 4 Global In Vitro Diagnostics Market By Reagents & Kits, Market forecast (2017-2028) (US $MN)
  • Table 5 Global In Vitro Diagnostics Market By Instruments, Market forecast (2017-2028) (US $MN)
  • Table 6 Global In Vitro Diagnostics Market By Software and services, Market forecast (2017-2028) (US $MN)
  • Table 7 Global In Vitro Diagnostics Market By Consumables, Market forecast (2017-2028) (US $MN)
  • Table 8 Global In Vitro Diagnostics Market By Application, Market forecast (2017-2028) (US $MN)
  • Table 9 Global In Vitro Diagnostics Market By Cancer, Market forecast (2017-2028) (US $MN)
  • Table 10 Global In Vitro Diagnostics Market By Cardiac diseases, Market forecast (2017-2028) (US $MN)
  • Table 11 Global In Vitro Diagnostics Market By Infectious Disease, Market forecast (2017-2028) (US $MN)
  • Table 12 Global In Vitro Diagnostics Market By Drug Testing/Pharmacogenomics, Market forecast (2017-2028) (US $MN)
  • Table 13 Global In Vitro Diagnostics Market By Cardiology, Market forecast (2017-2028) (US $MN)
  • Table 14 Global In Vitro Diagnostics Market By Diabetes, Market forecast (2017-2028) (US $MN)
  • Table 15 Global In Vitro Diagnostics Market By Nephrology, Market forecast (2017-2028) (US $MN)
  • Table 16 Global In Vitro Diagnostics Market By HIV/AIDS, Market forecast (2017-2028) (US $MN)
  • Table 17 Global In Vitro Diagnostics Market By Autoimmune Diseases, Market forecast (2017-2028) (US $MN)
  • Table 18 Global In Vitro Diagnostics Market By Other Applications, Market forecast (2017-2028) (US $MN)
  • Table 19 Global In Vitro Diagnostics Market By Technology, Market forecast (2017-2028) (US $MN)
  • Table 20 Global In Vitro Diagnostics Market By Molecular Diagnostics (MDX), Market forecast (2017-2028) (US $MN)
  • Table 21 Global In Vitro Diagnostics Market By Polymerase Chain Reaction (PCR), Market forecast (2017-2028) (US $MN)
  • Table 22 Global In Vitro Diagnostics Market By Hybridization, Market forecast (2017-2028) (US $MN)
  • Table 23 Global In Vitro Diagnostics Market By Isothermal Nucleic Acid Amplification Technology (INAAT), Market forecast (2017-2028) (US $MN)
  • Table 24 Global In Vitro Diagnostics Market By Microarray, Market forecast (2017-2028) (US $MN)
  • Table 25 Global In Vitro Diagnostics Market By DNA diagnostics, Market forecast (2017-2028) (US $MN)
  • Table 26 Global In Vitro Diagnostics Market By Other MDX Technologies, Market forecast (2017-2028) (US $MN)
  • Table 27 Global In Vitro Diagnostics Market By Immunochemistry/Immunoassays, Market forecast (2017-2028) (US $MN)
  • Table 28 Global In Vitro Diagnostics Market By Enzyme-Linked Immunosorbent Assay (ELISA), Market forecast (2017-2028) (US $MN)
  • Table 29 Global In Vitro Diagnostics Market By Western Blot, Market forecast (2017-2028) (US $MN)
  • Table 30 Global In Vitro Diagnostics Market By Rapid Tests, Market forecast (2017-2028) (US $MN)
  • Table 31 Global In Vitro Diagnostics Market By Radioimmunoassay (RIA) , Market forecast (2017-2028) (US $MN)
  • Table 32 Global In Vitro Diagnostics Market By Enzyme-Linked Immunospot (Elispot) Assay, Market forecast (2017-2028) (US $MN)
  • Table 33 Global In Vitro Diagnostics Market By Clinical Chemistry, Market forecast (2017-2028) (US $MN)
  • Table 34 Global In Vitro Diagnostics Market By Liver Panel, Market forecast (2017-2028) (US $MN)
  • Table 35 Global In Vitro Diagnostics Market By Renal Profile, Market forecast (2017-2028) (US $MN)
  • Table 36 Global In Vitro Diagnostics Market By Electrolyte Panel, Market forecast (2017-2028) (US $MN)
  • Table 37 Global In Vitro Diagnostics Market By Basic Metabolic Panel, Market forecast (2017-2028) (US $MN)
  • Table 38 Global In Vitro Diagnostics Market By Thyroid Function Panel, Market forecast (2017-2028) (US $MN)
  • Table 39 Global In Vitro Diagnostics Market By Specialty Chemical Tests, Market forecast (2017-2028) (US $MN)
  • Table 40 Global In Vitro Diagnostics Market By Clinical Microbiology, Market forecast (2017-2028) (US $MN)
  • Table 41 Global In Vitro Diagnostics Market By Coagulation and Hemostasis, Market forecast (2017-2028) (US $MN)
  • Table 42 Global In Vitro Diagnostics Market By Hematology, Market forecast (2017-2028) (US $MN)
  • Table 43 Global In Vitro Diagnostics Market By Other IVD Technologies, Market forecast (2017-2028) (US $MN)
  • Table 44 Global In Vitro Diagnostics Market By End-User, Market forecast (2017-2028) (US $MN)
  • Table 45 Global In Vitro Diagnostics Market By Standalone laboratories, Market forecast (2017-2028) (US $MN)
  • Table 46 Global In Vitro Diagnostics Market By Hospitals, Market forecast (2017-2028) (US $MN)
  • Table 47 Global In Vitro Diagnostics Market By Academic Institutes, Market forecast (2017-2028) (US $MN)
  • Table 48 Global In Vitro Diagnostics Market By Patient Self-Testing, Market forecast (2017-2028) (US $MN)
  • Table 49 Global In Vitro Diagnostics Market By Point-Of-Care Testing, Market forecast (2017-2028) (US $MN)
  • Table 50 Global In Vitro Diagnostics Market By Other End-Users, Market forecast (2017-2028) (US $MN)

Note: Regional tables for North America, Europe, Asia Pacific, Middle East, Latin America and RoW are presented in similar manner as the above

目次

The Global In- vitro diagnostics market is poised to grow at a CAGR of around 5.5% by 2028. Some of the prominent trends that the market is witnessing are growing healthcare expenditure in the emerging markets, huge demand for technologically advanced testing methods, raising incidences of chronic disease and growth opportunities/investment opportunities.

Based on product the market is categorized into data management software, reagents & kits, instruments, software and services and consumables.

By application the market is segmented into cancer, cardiac diseases, infectious disease, drug testing/pharmacogenomics, cardiology, diabetes, nephrology, HIV/AIDS, autoimmune diseases and other applications.

Depending on technology the market is segregated by Molecular Diagnostics (MDX), immunochemistry/immunoassays, clinical chemistry, clinical microbiology, coagulation and haemostasis, haematology and other IVD technologies. Furthermore molecular diagnostics (MDX) is segmented by polymerase chain reaction (PCR), hybridization, isothermal nucleic acid amplification technology (INAAT), microarray, DNA diagnostics and other MDX technologies.

Immunochemistry/Immunoassays are divided into enzyme-linked immunosorbent assay (ELISA), western blot, rapid tests, radioimmunoassay (RIA) and enzyme-linked immunospot (Elispot) assay. Clinical chemistry is categorized into liver panel, renal profile, electrolyte panel, basic metabolic panel, thyroid function panel and specialty chemical tests.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2017, 2018 revenue estimations are presented for 2019 and forecasts till 2028. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America

  • US
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific

Middle East

  • Saudi Arabia
  • UAE
  • Rest of Middle East

Latin America

  • Argentina
  • Brazil
  • Rest of Latin America

Rest of the World

  • Africa
  • Caribbean

Report Highlights:

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2028, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2028
  • Market opportunities and recommendations for new investments

Table of Contents

1 Market Outline

  • 1.1 Research Methodology
    • 1.1.1 Research Approach & Sources
  • 1.2 Market Trends
  • 1.3 Regulatory Factors
  • 1.4 Technology Analysis
  • 1.5 Product Analysis
  • 1.6 Application Analysis
  • 1.7 End- User Analysis
  • 1.8 Strategic Benchmarking
  • 1.9 Opportunity Analysis

2 Executive Summary

3 Market Overview

  • 3.1 Current Trends
    • 3.1.1 Growing Healthcare Expenditure in the Emerging Markets
    • 3.1.2 Huge Demand for Technologically Advanced Testing Methods
    • 3.1.3 Raising Incidences of Chronic Diseases
    • 3.1.4 Growth Opportunities/Investment Opportunites
  • 3.2 Drivers
  • 3.3 Constraints
  • 3.4 Industry Attractiveness
    • 3.4.1 Bargaining power of suppliers
    • 3.4.2 Bargaining power of buyers
    • 3.4.3 Threat of substitutes
    • 3.4.4 Threat of new entrants
    • 3.4.5 Competitive rivalry

4 Global In- Vitro Daiagnostics Market, By Product

  • 4.1 Data Management Software
    • 4.1.1 Data Management Software Market forecast to 2028 (US$ MN)
  • 4.2 Reagents & Kits
    • 4.2.1 Reagents & Kits Market forecast to 2028 (US$ MN)
  • 4.3 Instruments
    • 4.3.1 Instruments Market forecast to 2028 (US$ MN)
  • 4.4 Software and services
    • 4.4.1 Software and services Market forecast to 2028 (US$ MN)
  • 4.5 Consumables
    • 4.5.1 Consumables Market forecast to 2028 (US$ MN)

5 Global In Vitro Diagnostics Market, By Application

  • 5.1 Cancer
    • 5.1.1 Cancer Market forecast to 2028 (US$ MN)
  • 5.2 Cardiac diseases
    • 5.2.1 Cardiac diseases Market forecast to 2028 (US$ MN)
  • 5.3 Infectious Disease
    • 5.3.1 Infectious Disease Market forecast to 2028 (US$ MN)
  • 5.4 Drug Testing/Pharmacogenomics
    • 5.4.1 Drug Testing/Pharmacogenomics Market forecast to 2028 (US$ MN)
  • 5.5 Cardiology
    • 5.5.1 Cardiology Market forecast to 2028 (US$ MN)
  • 5.6 Diabetes
    • 5.6.1 Diabetes Market forecast to 2028 (US$ MN)
  • 5.7 Nephrology
    • 5.7.1 Nephrology Market forecast to 2028 (US$ MN)
  • 5.8 HIV/AIDS
    • 5.8.1 HIV/AIDS Market forecast to 2028 (US$ MN)
  • 5.9 Autoimmune Diseases
    • 5.9.1 Autoimmune Diseases Market forecast to 2028 (US$ MN)
  • 5.10 Other Applications
    • 5.10.1 Other Applications Market forecast to 2028 (US$ MN)

6 Global In Vitro Diagnostics Market, By Technology

  • 6.1 Molecular Diagnostics (MDX)
    • 6.1.1 Molecular Diagnostics (MDX) Market forecast to 2028 (US$ MN)
      • 6.1.1.1 Polymerase Chain Reaction (PCR)
      • 6.1.1.1.1 Polymerase Chain Reaction (PCR) Market forecast to 2028 (US$ MN)
      • 6.1.1.2 Hybridization
      • 6.1.1.2.1 Hybridization Market forecast to 2028 (US$ MN)
      • 6.1.1.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
      • 6.1.1.3.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market forecast to 2028 (US$ MN)
      • 6.1.1.4 Microarray
      • 6.1.1.4.1 Microarray Market forecast to 2028 (US$ MN)
      • 6.1.1.5 DNA diagnostics
      • 6.1.1.5.1 DNA diagnostics Market forecast to 2028 (US$ MN)
      • 6.1.1.6 Other MDX Technologies
      • 6.1.1.6.1 Other MDX Technologies Market forecast to 2028 (US$ MN)
  • 6.2 Immunochemistry/Immunoassays
    • 6.2.1 Immunochemistry/Immunoassays Market forecast to 2028 (US$ MN)
      • 6.2.1.1 Enzyme-Linked Immunosorbent Assay (ELISA)
      • 6.2.1.1.1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Forecast By Type to 2028 (US$ MN)
      • 6.2.1.1.1.1 Chemiluminescence Immunoassays (CLIAS)
      • 6.2.1.1.1.2 Fluorescence Immunoassays (FIAS)
      • 6.2.1.1.1.3 Colorimetric Immunoassays (CIS)
      • 6.2.1.2 Western Blot
      • 6.2.1.2.1 Western Blot Market forecast to 2028 (US$ MN)
      • 6.2.1.3 Rapid Tests
      • 6.2.1.3.1 Rapid Tests Market forecast to 2028 (US$ MN)
      • 6.2.1.4 Radioimmunoassay (RIA)
      • 6.2.1.4.1 Radioimmunoassay (RIA) Market forecast to 2028 (US$ MN)
      • 6.2.1.5 Enzyme-Linked Immunospot (Elispot) Assay
      • 6.2.1.5.1 Enzyme-Linked Immunospot (Elispot) Assay Market forecast to 2028 (US$ MN)
  • 6.3 Clinical Chemistry
    • 6.3.1 Clinical Chemistry Market forecast to 2028 (US$ MN)
      • 6.3.1.1 Liver Panel
      • 6.3.1.1.1 Liver Panel Market forecast to 2028 (US$ MN)
      • 6.3.1.2 Renal Profile
      • 6.3.1.2.1 Renal Profile Market forecast to 2028 (US$ MN)
      • 6.3.1.3 Electrolyte Panel
      • 6.3.1.3.1 Electrolyte Panel Market forecast to 2028 (US$ MN)
      • 6.3.1.4 Basic Metabolic Panel
      • 6.3.1.4.1 Basic Metabolic Panel Market forecast to 2028 (US$ MN)
      • 6.3.1.5 Thyroid Function Panel
      • 6.3.1.5.1 Thyroid Function Panel Market forecast to 2028 (US$ MN)
      • 6.3.1.6 Specialty Chemical Tests
      • 6.3.1.6.1 Specialty Chemical Tests Market forecast to 2028 (US$ MN)
      • 6.3.1.7.1 Lipid Profile
      • 6.3.1.7.1.1 Lipid Profile Market forecast to 2028 (US$ MN)
  • 6.4 Clinical Microbiology
    • 6.4.1 Clinical Microbiology Market forecast to 2028 (US$ MN)
  • 6.5 Coagulation and Hemostasis
    • 6.5.1 Coagulation and Hemostasis Market forecast to 2028 (US$ MN)
  • 6.6 Hematology
    • 6.6.1 Hematology Market forecast to 2028 (US$ MN)
  • 6.7 Other IVD Technologies
    • 6.7.1 Other IVD Technologies Market forecast to 2028 (US$ MN)

7 Global In Vitro Diagnostics Market, By End-User

  • 7.1 Standalone laboratories
    • 7.1.1 Standalone laboratories Market forecast to 2028 (US$ MN)
  • 7.2 Hospitals
    • 7.2.1 Hospitals Market forecast to 2028 (US$ MN)
  • 7.3 Academic Institutes
    • 7.3.1 Academic Institutes Market forecast to 2028 (US$ MN)
  • 7.4 Patient Self-Testing
    • 7.4.1 Patient Self-Testing Market forecast to 2028 (US$ MN)
  • 7.5 Point-Of-Care Testing
    • 7.5.1 Point-Of-Care Testing Market forecast to 2028 (US$ MN)
  • 7.6 Other End-Users
    • 7.6.1 Other End-Users Market forecast to 2028 (US$ MN)

8 Global In Vitro Diagnostics Market, By Geography

  • 8.1 North America
    • 8.1.1 North America Market forecast by Countries to 2028 (US$ MN)
      • 8.1.1.1 US
      • 8.1.1.2 Canada
      • 8.1.1.3 Mexico
  • 8.2 Europe
    • 8.2.1 Europe Market forecast by Countries to 2028 (US$ MN)
      • 8.2.1.1 Germany
      • 8.2.1.2 U.K.
      • 8.2.1.3 Italy
      • 8.2.1.4 France
      • 8.2.1.5 Spain
      • 8.2.1.6 Rest of Europe
  • 8.3 Asia Pacific
    • 8.3.1 Asia Pacific Market forecast by Countries to 2028 (US$ MN)
      • 8.3.1.1 Japan
      • 8.3.1.2 China
      • 8.3.1.3 India
      • 8.3.1.4 Australia
      • 8.3.1.5 New Zealand
      • 8.3.1.6 Rest of APAC
  • 8.4 Middle East
    • 8.4.1 Middle East Market forecast by Countries to 2028 (US$ MN)
      • 8.4.1.1 Saudi Arabia
      • 8.4.1.2 UAE
      • 8.4.1.3 Rest of Middle East
  • 8.5 Latin America
    • 8.5.1 Latin America Market forecast by Countries to 2028 (US$ MN)
      • 8.5.1.1 Argentina
      • 8.5.1.2 Brazil
      • 8.5.1.3 Rest of Latin America
  • 8.6 Rest of the World (RoW)
    • 8.6.1 RoW Market forecast by Countries to 2028 (US$ MN)
      • 8.6.1.1 Africa
      • 8.6.1.2 Caribbean

9 Key Player Activities

  • 9.1 Mergers & Acquisitions
  • 9.2 Partnerships, Joint Venture's, Collaborations and Agreements
  • 9.3 Product Launch & Expansions
  • 9.4 Other Activities

10 Leading Companies

  • 10.1 Johnson & Johnson
  • 10.2 Sysmex Corporation
  • 10.3 Biomerieux SA
  • 10.4 Becton, Dickinson and Company
  • 10.5 Danaher Corporation
  • 10.6 Alere Inc.
  • 10.7 Thermo Fisher Scientific, Inc.
  • 10.8 Bristol-Myers Squibb Company
  • 10.9 Abbott Laboratories, Inc.
  • 10.10 Ortho-Clinical Diagnostics, Inc.
  • 10.11 Diasorin S.P.A.
  • 10.12 Bio-Rad Laboratories, Inc.
  • 10.13 Siemens AG
  • 10.14 Arkray, Inc.
  • 10.15 Qiagen N.V.
  • 10.16 Roche Diagnostics
  • 10.17 Affymetrix Inc.